Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Aiko, Hayashi"'
Autor:
Mayumi Shoji, Naoya Teramoto, Takahiro Ishikawa, Aiko Hayashi, Ai Matsumoto, Hidetoshi Ochiai, Ayano Yamaguchi, Yukari Maeda, Atsushi Takasaki, Chihiro Hiraga, Shintaro Ide, Kana Ide, Masashi Yamamoto, Yoshiro Maezawa, Ayako Shigeta, Seiichiro Sakao, Takuji Suzuki, Misuzu Yahaba, Toshihumi Taniguchi, Hidetoshi Igari, Koutaro Yokote, Masaya Koshizaka
Publikováno v:
Endocrine and Metabolic Science, Vol 16, Iss , Pp 100196- (2024)
Introduction: To elucidate factors associated with severe disease in patients with coronavirus disease 2019 (COVID-19) pneumonia complicated with diabetes mellitus. Methods: Among patients with COVID-19 pneumonia hospitalized from January to Septembe
Externí odkaz:
https://doaj.org/article/c53ef8aaa5d041a4b3cf721a4fb71a16
Autor:
Toshiki Namiki, Minoru Takemoto, Aiko Hayashi, Hiroki Yamagata, Takahiro Ishikawa, Koutaro Yokote, Shu-Yang Li, Masaaki Kubota, Bo-Shi Zhang, Yoichi Yoshida, Tomoo Matsutani, Seiichiro Mine, Toshio Machida, Yoshio Kobayashi, Jiro Terada, Akira Naito, Koichiro Tatsumi, Hirotaka Takizawa, Rika Nakamura, Hideyuki Kuroda, Yasuo Iwadate, Takaki Hiwasa
Publikováno v:
BMC Endocrine Disorders, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Autoantibodies develop in autoimmune diseases, cancer, diabetes mellitus (DM), and atherosclerosis-related diseases. However, autoantibody biomarkers have not been successfully examined for diagnosis and therapy. Methods Serologic
Externí odkaz:
https://doaj.org/article/cdd10618ca81486f9f8b501d8fd1cd27
Autor:
Minoru Takemoto, Aiko Hayashi, Yosuke Inaba, Tomohiro Tanaka, Tae‐Hwa Chun, Hideki Hayashi, Kazunori Kasama, Atsuhito Saiki, Akira Sasaki, Shinichi Okazumi, Hisahiro Matsubara, Ichiro Tatsuno
Publikováno v:
Annals of Gastroenterological Surgery, Vol 7, Iss 5, Pp 750-756 (2023)
Abstract Aim According to the current guidelines in Japan, the upper age limit for bariatric and metabolic surgery is 65 y. This study aimed to examine the appropriateness of this upper age limit. Methods Using the database maintained by the Japanese
Externí odkaz:
https://doaj.org/article/4cd6d70f1ae44dd9a21bf3932920b831
Autor:
Hiroki Yamagata, Aiko Hayashi, Yoich Yoshida, Masaya Koshizaka, Shunichiro Onishi, Tomohiko Yoshida, Takaki Hiwasa, Minoru Takemoto
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract In addition to pathogenic autoantibodies, polyclonal autoantibodies with unknown physiological roles and pathogenicity are produced in the body. Moreover, serum antibodies against the proprotein convertase subtilisin/kexin type 9 (PCSK9) pro
Externí odkaz:
https://doaj.org/article/8ba523a3389043c196e170f0f89444b9
Autor:
Shu-Yang Li, Yoichi Yoshida, Masaaki Kubota, Bo-Shi Zhang, Tomoo Matsutani, Masaaki Ito, Satoshi Yajima, Kimihiko Yoshida, Seiichiro Mine, Toshio Machida, Aiko Hayashi, Minoru Takemoto, Koutaro Yokote, Mikiko Ohno, Eiichiro Nishi, Kenichiro Kitamura, Ikuo Kamitsukasa, Hirotaka Takizawa, Mizuki Sata, Kazumasa Yamagishi, Hiroyasu Iso, Norie Sawada, Shoichiro Tsugane, Katsuro Iwase, Hideaki Shimada, Yasuo Iwadate, Takaki Hiwasa
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
IntroductionAutoantibodies against inflammatory cytokines may be used for the prevention of atherosclerosis. Preclinical studies consider colony-stimulating factor 2 (CSF2) as an essential cytokine with a causal relationship to atherosclerosis and ca
Externí odkaz:
https://doaj.org/article/35788a9a94f345eab5c3423a98b90c80
Autor:
TAKAKI HIWASA, YOICHI YOSHIDA, MASAAKI KUBOTA, SHU‑YANG LI, BO‑SHI ZHANG, TOMOO MATSUTANI, SEIICHIRO MINE, TOSHIO MACHIDA, MASAAKI ITO, SATOSHI YAJIMA, MIKAKO SHIROUZU, SHIGEYUKI YOKOYAMA, MIZUKI SATA, KAZUMASA YAMAGISHI, HIROYASU ISO, NORIE SAWADA, SHOICHIRO TSUGANE, MINORU TAKEMOTO, AIKO HAYASHI, KOUTARO YOKOTE
Publikováno v:
Medicine International (2754-3242); Sep/Oct2024, Vol. 4 Issue 5, p1-14, 14p
Autor:
Daisuke Kinoshita, Hisaya Kato, Hiyori Kaneko, Takahiro Ishikawa, Naoya Teramoto, Ayano Tsukagoshi, Yukari Maeda, Takuya Minamizuka, Aiko Hayashi, Mayumi Shoji, Daisuke Sawada, Shinichiro Funayama, Masaya Koshizaka, Hideyuki Ogata, Yoshitaka Kubota, Nobuyuki Mitsukawa, Minoru Takemoto, Koutaro Yokote, Yoshiro Maezawa
Publikováno v:
Geriatrics & Gerontology International. 23:239-241
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8801e2b1b0835708bd0b49e86a351998
https://doi.org/10.1111/ggi.14546
https://doi.org/10.1111/ggi.14546
Autor:
Toshiki Namiki, Minoru Takemoto, Aiko Hayashi, Hiroki Yamagata, Takahiro Ishikawa, Koutaro Yokote, Shu-Yang Li, Masaaki Kubota, Bo-Shi Zhang, Yoichi Yoshida, Tomoo Matsutani, Seiichiro Mine, Toshio Machida, Yoshio Kobayashi, Jiro Terada, Akira Naito, Koichiro Tatsumi, Hirotaka Takizawa, Rika Nakamura, Hideyuki Kuroda, Yasuo Iwadate, Takaki Hiwasa
Background: Autoantibodies develop in autoimmune diseases, cancer, diabetes mellitus (DM),and atherosclerosis-related diseases. However, autoantibody biomarkers have not been successfully examined for diagnosis and therapy. Methods: Serological ident
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dff754b3360de5652b89649d4455d5f9
https://doi.org/10.21203/rs.3.rs-2493375/v1
https://doi.org/10.21203/rs.3.rs-2493375/v1
Autor:
Hiroki Yamagata, Aiko Hayashi, Yoich Yoshida, Masaya Koshizaka, Shunichiro Onishi, Tomohiko Yohida, Takaki Hiwasa, Minoru Takemoto
Background In addition to pathogenic autoantibodies, polyclonal autoantibodies with unknown physiological roles and pathogenicity are produced in the body. Moreover, serum antibodies against the proprotein convertase subtilisin/kexin type 9 (PCSK9) p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10af8bfe86343a611cf81e073561aefc
https://doi.org/10.21203/rs.3.rs-2435059/v1
https://doi.org/10.21203/rs.3.rs-2435059/v1
Autor:
Hiroki Yamagata, Aiko Hayashi, Yoich Yoshida, Masaya Koshizaka, Shunichiro Onishi, Tomohiko Yohida, Takaki Hiwasa, Minoru Takemoto
Background In addition to pathogenic autoantibodies, polyclonal autoantibodies with unknown physiological roles and pathogenicity are produced in the body. Moreover, serum antibodies against the proprotein convertase subtilisin/kexin type 9 (PCSK9) p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ed18de132c4cf0d6db64a46cb5454dc
https://doi.org/10.21203/rs.3.rs-2420850/v1
https://doi.org/10.21203/rs.3.rs-2420850/v1